ChatDocto
Find a doctor
Ampoule containing solution for injection

ABEVMY 400 mg(25mg/ml)

BEVACIZUMAB · concentrate for infusion

B/1FL/16mlInjection
See all pack prices
Strength400 mg(25mg/ml)
Therapeutic classANTINEOPLASIQUES ET IMMUNOMODULATEURS
ATC codeL01FG01

About this medicine

ABEVMY 400 mg(25mg/ml) concentrate for infusion is listed in Tunisia's medicine catalog under the active ingredient BEVACIZUMAB. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/1FL/16ml

    Price not recorded
    AMM No.
    20343022H
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formconcentrate for infusion
Route of administrationInjection
LaboratoryMYLAN PHARMACEUTICALS PRIVATE LIMITED
OriginBiosimilar
ScheduleA
ATC codeL01FG01 — Bévacizumab
Therapeutic classANTINEOPLASIQUES ET IMMUNOMODULATEURS